Literature DB >> 9189051

Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?

B M Brinkman1, T W Huizinga, S S Kurban, E A van der Velde, G M Schreuder, J M Hazes, F C Breedveld, C L Verweij.   

Abstract

Genetic factors associated with rheumatoid arthritis (RA) might involve variant tumour necrosis factor (TNF)-alpha genes. Therefore, polymorphisms at positions -308, -238, -376, -163 and +70 relative to the transcription initiation site were studied with respect to the susceptibility to, or severity of, RA. TNF-alpha genotypes of 283 RA patients and 116 healthy individuals were determined. Clinical data were obtained from patient files and questionnaires. The distribution of TNF-alpha alleles was similar in RA patients and healthy controls. With respect to disease severity, the TNF-alpha -238GA genotype was found to be associated with the absence of erosions [odds ratio (OR) 4.1, confidence interval 1.0-17]. In addition, this genotype was associated with a lower number of hand joints affected by erosions within the first 3 yr of disease onset compared to -238GG. The association between the -238 polymorphism and radiographic progression was independent of the presence of HLA-DR4. In line with this observation, the OR for the presence of erosions in patients with both risk factors (DR4 and -238GG) compared to patients who lack these factors was 11.1 (1.8-6.8). No associations between the TNF-alpha -308, +70 and -376 alleles and susceptibility to, or severity of, RA could be demonstrated. Our data indicate that the TNF-alpha -238GA genotype is associated with decreased radiologically detectable progression of RA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9189051     DOI: 10.1093/rheumatology/36.5.516

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  40 in total

Review 1.  Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis.

Authors:  C L Verweij
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Biologic therapies in rheumatoid arthritis.

Authors:  K J Bulpitt
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

Review 3.  Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models.

Authors:  S R Ruuls; J D Sedgwick
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 4.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

5.  The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction.

Authors:  H Marotte; P Farge; P Gaudin; C Alexandre; B Mougin; P Miossec
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

6.  The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population.

Authors:  H Marotte; B Pallot-Prades; L Grange; J Tebib; P Gaudin; C Alexandre; J L Blond; M A Cazalis; B Mougin; P Miossec
Journal:  Ann Rheum Dis       Date:  2005-08-11       Impact factor: 19.103

7.  FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians.

Authors:  Mohamed M Thabet; J Wesoly; P E Slagboom; R E M Toes; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2006-12-19       Impact factor: 19.103

8.  Tumour necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis.

Authors:  Zahra Rezaieyazdi; Jalil Tavakol Afshari; Mahnaz Sandooghi; Farnaz Mohajer
Journal:  Rheumatol Int       Date:  2007-08-29       Impact factor: 2.631

9.  Tumor necrosis factor alpha -308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China.

Authors:  Ruiwen Chen; Meng Fang; Qing Cai; Shiwei Duan; Ke Lv; Ning Cheng; Daming Ren; Jie Shen; Dongyi He; Lin He; Shuhan Sun
Journal:  Rheumatol Int       Date:  2007-08-21       Impact factor: 2.631

10.  Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population.

Authors:  Deepali Gambhir; Able Lawrence; Amita Aggarwal; Ramnath Misra; Sudhir Kumar Mandal; Sita Naik
Journal:  Rheumatol Int       Date:  2009-09-25       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.